Email : info@nexusalliancebiopharma.com
Contact : (321) 445-1969

Novel targets and breast cancer treatment.

Abstract

Breast cancer is the second most common cancer in women, after skin cancer. One out of every 8 woman in the United States will develop breast cancer. It can be caused by genetic mutations, using certain medicines, or even hereditary disorders. Traditionally, breast cancer would be treated through surgery, radiation therapy or chemotherapy. However, a new kind of treatment therapy, targeted therapy, has been subject to serious consideration. This kind of therapy mainly focuses on the molecular pathways responsible in process of carcinogenesis, tumor promotion and metastasis. In this paper, we discuss the causes, epidemiology, and potential targeted therapies techniques to treat breast cancer.

Key words: Breast cancer, immunotherapy, estrogen, monoclonal antibodies, T-cell therapy, vaccines, checkpoint inhibitors

Download Pdf